Skip to main content

Client News

AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin

17th July 2023

Rentschler Biopharma: Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim

12th July 2023

Carbios announces the success of its capital increase with preferential subscription rights of approximately 141 million euros, the largest on Euronext Growth since 2015

11th July 2023

Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors

11th July 2023

Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation

11th July 2023

Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides

6th July 2023

AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients

6th July 2023

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

6th July 2023

Destiny Pharma: Positive Findings from Recent SAB Meeting

6th July 2023

Destiny Pharma: Business Update

29th June 2023